Abstract
Methamphetamine (METH) is a powerful psychostimulant that is causing serious health problems worldwide owing to imprudent abuses. Recent studies have suggested that METH has deleterious effects on the blood–brain barrier (BBB). A few studies have also been conducted on the mechanisms whereby METH-induced oxidative stress causes BBB dysfunction. We investigated whether N-tert-butyl-α-phenylnitrone (PBN) has protective effects on BBB function against METH exposure in primary human brain microvascular endothelial cells (HBMECs). We found that METH significantly increased reactive oxygen species (ROS) generation in HBMECs. Pretreatment with PBN decreased METH-induced ROS production. With regard to BBB functional integrity, METH exposure elevated the paracellular permeability and reduced the monolayer integrity; PBN treatment reversed these effects. An analysis of the BBB structural properties, by immunostaining junction proteins and cytoskeleton in HBMECs, indicated that METH treatment changed the cellular localization of the tight (ZO-1) and adherens junctions (VE-cadherin) from the membrane to cytoplasm. Furthermore, METH induced cytoskeletal reorganization via the formation of robust stress fibers. METH-induced junctional protein redistribution and cytoskeletal reorganization were attenuated by PBN treatment. Our results suggest that PBN can act as a therapeutic reagent for METH-induced BBB dysfunction by inhibiting excess ROS generation.
This is a preview of subscription content, access via your institution.
References
Ballabh P, Braun A, Nedergaard M (2004) The blood–brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16:1–13. https://doi.org/10.1016/j.nbd.2003.12.016
Blasig IE, Haseloff RF (2011) Tight junctions and tissue barriers. Antioxid Redox Signal 15:1163–1166. https://doi.org/10.1089/ars.2011.4003
Bowyer JF, Ali S (2006) High doses of methamphetamine that cause disruption of the blood–brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus. Synapse 60:521–532. https://doi.org/10.1002/syn.20324
Burridge K, Wittchen ES (2013) The tension mounts: stress fibers as force-generating mechanotransducers. J Cell Biol 200:9–19. https://doi.org/10.1083/jcb.201210090
Cao XH, Phillis JW (1994) Alpha-phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Res 644:267–272. https://doi.org/10.1016/0006-8993(94)91689-6
Choi YK, Maki T, Mandeville ET, Koh SH, Hayakawa K, Arai K, Kim YM, Whalen MJ, Xing CH, Wang XY, Kim KW, Lo EH (2016) Dual effects of carbon monoxide on pericytes and neurogenesis in traumatic brain injury. Nat Med 22:1335–1341. https://doi.org/10.1038/nm.4188
Coelho-Santos V, Leitao RA, Cardoso FL, Palmela I, Rito M, Barbosa M, Brito MA, Fontes-Ribeiro CA, Silva AP (2015) The TNF-alpha/NF-kappa B signaling pathway has a key role in methamphetamine-induced blood–brain barrier dysfunction. J Cereb Blood Flow Metab 35:1260–1271. https://doi.org/10.1038/jcbfm.2015.59
Daneman R, Prat A (2015) The blood–brain barrier. Cold Spring Harb Perspect Biol 7:a020412. https://doi.org/10.1101/cshperspect.a020412
Di A, Mehta D, Malik AB (2016) ROS-activated calcium signaling mechanisms regulating endothelial barrier function. Cell Calcium 60:163–171. https://doi.org/10.1016/j.ceca.2016.02.002
Dumont M, Beal MF (2011) Neuroprotective strategies involving ROS in Alzheimer disease. Free Radic Biol Med 51:1014–1026. https://doi.org/10.1016/j.freeradbiomed.2010.11.026
Farooque M, Olsson Y (1997) Pretreatment with alpha-phenyl-N-tert-butyl-nitrone (PBN) improves energy metabolism after spinal cord injury in rats. J Neurotrauma 14(7):469–476. https://doi.org/10.1089/neu.1997.14.469
Floyd RA, Neto HCCF, Zimmerman GA, Hensley K, Towner RA (2013) Nitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines. Free Radic Biol Med 62:145–156. https://doi.org/10.1016/j.freeradbiomed.2013.01.033
Gilmont RR, Dardano A, Young M, Engle JS, Adamson BS, Smith DJ, Rees RS (1998) Effects of glutathione depletion on oxidant-induced endothelial cell injury. J Surg Res 80:62–68. https://doi.org/10.1006/jsre.1998.5328
Gold MS, Kobeissy FH, Wang KKW, Merlo LJ, Bruijnzeel AW, Krasnova IN, Cadet JL (2009) Methamphetamine- and trauma-induced brain injuries: comparative cellular and molecular neurobiological substrates. Biol Psychiatry 66:118–127. https://doi.org/10.1016/j.biopsych.2009.02.021
Himadri P, Kumari SS, Chitharanjan M, Dhananjay S (2010) Role of oxidative stress and inflammation in hypoxia-induced cerebral edema: a molecular approach. High Alt Med Biol 11:231–244. https://doi.org/10.1089/ham.2009.1057
Huynh DTN, Heo KS (2019) Therapeutic targets for endothelial dysfunction in vascular diseases. Arch Pharmacal Res 42:848–861. https://doi.org/10.1007/s12272-019-01180-7
Hwang JS, Cha EH, Ha EY, Park BD, Seo JH (2020) GKT136901 protects primary human brain microvascular endothelial cells against methamphetamine-induced blood–brain barrier dysfunction. Life Sci 256:117917. https://doi.org/10.1016/j.lfs.2020.117917
Jackson S, Meeks C, Vezina A, Robey RW, Tanner K, Gottesman MM (2019) Model systems for studying the blood–brain barrier: applications and challenges. Biomaterials 214:119217. https://doi.org/10.1016/j.biomaterials.2019.05.028
Jang EY, Ryu YH, Lee BH, Chang SC, Yeo MJ, Kim SH, Folsom RJ, Schilaty ND, Kim KJ, Yang CH, Steffensen SC, Kim HY (2015) Involvement of reactive oxygen species in cocaine-taking behaviors in rats. Addict Biol 20:663–675. https://doi.org/10.1111/adb.12159
Jayaraj RL, Azimullah S, Beiram R, Jalal FY, Rosenberg GA (2019) Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflamm 16:142. https://doi.org/10.1186/s12974-019-1516-2
Kevil CG, Goeders NE, Woolard MD, Bhuiyan MS, Dominic P, Kolluru GK, Arnold CL, Traylor JG, Orr AW (2019) Methamphetamine use and cardiovascular disease in search of answers. Arterioscler Thromb Vasc Biol 39:1739–1746. https://doi.org/10.1161/Atvbaha.119.312461
Kim HK, Zhang YP, Gwak YS, Abdi S (2010) Phenyl n-tert-butylnitrone, a free radical scavenger, reduces mechanical allodynia in chemotherapy-induced neuropathic pain in rats. Anesthesiology 112:432–439. https://doi.org/10.1097/ALN.0b013e3181ca31bd
Krasnova IN, Cadet JL (2009) Methamphetamine toxicity and messengers of death. Brain Res Rev 60:379–407. https://doi.org/10.1016/j.brainresrev.2009.03.002
Kubova H, Folbergrova J, Rejchrtova J, Tsenov G, Parizkova M, Burchfiel J, Mikulecka A, Mares P (2018) The free radical scavenger n-tert-butyl-alpha-phenylnitrone (PBN) administered to immature rats during status epilepticus alters neurogenesis and has variable effects, both beneficial and detrimental, on long-term outcomes. Front Cell Neurosci 12:266. https://doi.org/10.3389/fncel.2018.00266
Lappin JM, Darke S, Farrell M (2017) Stroke and methamphetamine use in young adults: a review. J Neurol Neurosurg Psychiatry 88:1079–1091. https://doi.org/10.1136/jnnp-2017-316071
Lee JH, Park JW (2005) The effect of alpha-phenyl-n-t-butylnitrone on ionizing radiation-induced apoptosis in U937 cells. Free Radic Res 39:1325–1333. https://doi.org/10.1080/10715760500217215
Liu HQ, An YW, Hu AZ, Li MH, Wu JL, Liu L, Shi Y, Cui GH, Chen Y (2019) Critical roles of the PI3K-Akt-mTOR signaling pathway in apoptosis and autophagy of astrocytes induced by methamphetamine. Open Chem 17:96–104. https://doi.org/10.1515/chem-2019-0015
Lopez-Ramirez MA, Fischer R, Torres-Badillo CC, Davies HA, Logan K, Pfizenmaier K, Male DK, Sharrack B, Romero IA (2012) Role of caspases in cytokine-induced barrier breakdown in human brain endothelial cells. J Immunol 189:3130–3139. https://doi.org/10.4049/jimmunol.1103460
Marklund N, Clausen F, Lewen A, Hovda DA, Olsson Y, Hillered L (2001) Alpha-phenyl-tert-n-butyl nitrone (PBN) improves functional and morphological outcome after cortical contusion injury in the rat. Acta Neurochir 143:73–81. https://doi.org/10.1007/s007010170141
Marklund N, Lewander T, Clausen FH, Illered L (2001) Effects of the nitrone radical scavengers PBN and S-PBN on in vivo trapping of reactive oxygen species after traumatic brain injury in rats. J Cereb Blood Flow Metab 21:1259–1267. https://doi.org/10.1097/00004647-200111000-00002
Martins T, Burgoyne T, Kenny BA, Hudson N, Futter CE, Ambrosio AF, Silva AP, Greenwood J, Turowski P (2013) Methamphetamine-induced nitric oxide promotes vesicular transport in blood–brain barrier endothelial cells. Neuropharmacology 65:74–82. https://doi.org/10.1016/j.neuropharm.2012.08.021
Namyen J, Permpoonputtana K, Nopparat C, Tocharus J, Tocharus C, Govitrapong P (2020) Protective effects of melatonin on methamphetamine-induced blood–brain barrier dysfunction in rat model. Neurotox Res 37:640–660. https://doi.org/10.1007/s12640-019-00156-1
Natarajan R, Mitchell CM, Harless N, Yamamoto BK (2018) Cerebrovascular injury after serial exposure to chronic stress and abstinence from methamphetamine self-administration. Sci Rep 8:10558. https://doi.org/10.1038/s41598-018-28970-1
Northrop NA, Yamamoto BK (2015) Methamphetamine effects on blood–brain barrier structure and function. Front Neurosci Switz 9:69. https://doi.org/10.3389/fnins.2015.00069
Park S, Kang HJ, Jeon JH, Kim MJ, Lee IK (2019) Recent advances in the pathogenesis of microvascular complications in diabetes. Arch Pharmacal Res 42:252–262. https://doi.org/10.1007/s12272-019-01130-3
Pun PBL, Lu J, Moochhala S (2009) Involvement of ROS in BBB dysfunction. Free Radic Res 43:348–364. https://doi.org/10.1080/10715760902751902
Qie XJ, Wen D, Guo HY, Xu GJ, Liu S, Shen QC, Liu Y, Zhang WF, Cong B, Ma CL (2017) Endoplasmic reticulum stress mediates methamphetamine-induced blood–brain barrier damage. Front Pharmacol 8:639. https://doi.org/10.3389/fphar.2017.00639
Ramirez SH, Potula R, Fan S, Eidem T, Papugani A, Reichenbach N, Dykstra H, Weksler BB, Romero IA, Couraud PO, Persidsky Y (2009) Methamphetamine disrupts blood–brain barrier function by induction of oxidative stress in brain endothelial cells. J Cereb Blood Flow Metab 29:1933–1945. https://doi.org/10.1038/jcbfm.2009.112
Rao R (2008) Oxidative stress-induced disruption of epithelial and endothelial tight junctions. Front Biosci 13:7210–7226. https://doi.org/10.2741/3223
Sajja RK, Rahman S, Cucullo L (2016) Drugs of abuse and blood–brain barrier endothelial dysfunction: a focus on the role of oxidative stress. J Cereb Blood Flow Metab 36:539–554. https://doi.org/10.1177/0271678x15616978
Schaefer CP, Tome ME, Davis TP (2017) The opioid epidemic: a central role for the blood brain barrier in opioid analgesia and abuse . Fluids Barriers CNS 14:32. https://doi.org/10.1186/s12987-017-0080-3
Schreibelt G, Kooij G, Reijerkerk A, van Doorn R, Gringhuis SI, van der Pol S, Weksler BB, Romero IA, Couraud PO, Piontek J, Blasig IE, Dijkstra CD, Ronken E, de Vries HE (2007) Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J 21:3666–3676. https://doi.org/10.1096/fj.07-8329com
Schulz JB, Weller M, Klockgether T (1996) Potassium deprivation-induced apoptosis of cerebellar granule neurons: a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species. J Neurosci 16:4696–4706. https://doi.org/10.1523/JNEUROSCI.16-15-04696.1996
Seo MJ, Song SH, Kim S, Jang WJ, Jeong CH, Lee S (2020) Characteristics of Korean patients with methamphetamine use disorder based on the quantitative analysis of methamphetamine and amphetamine in hair. Arch Pharmacal Res 43:798–807. https://doi.org/10.1007/s12272-020-01259-6
Sharma HS, Ali SF (2006) Alterations in blood–brain barrier function by morphine and methamphetamine. Ann N Y Acad Sci 1074:198–224. https://doi.org/10.1196/annals.1369.020
Sharma HS, Muresanu D, Sharma A, Patnaik R (2009) Cocaine-induced breakdown of the blood–brain barrier and neurotoxicity. Int Rev Neurobiol 88:297–334. https://doi.org/10.1016/S0074-7742(09)88011-2
Shen L, Turner JR (2005) Actin depolymerization disrupts tight junctions via caveolae-mediated endocytosis. Mol Biol Cell 16:3919–3936. https://doi.org/10.1091/mbc.E04-12-1089
Shi YJ, Zhang LL, Pu HJ, Mao LL, Hu XM, Jiang XY, Xu N, Stetler RA, Zhang F, Liu XR, Leak RK, Keep RF, Ji XM, Chen J (2016) Rapid endothelial cytoskeletal reorganization enables early blood–brain barrier disruption and long-term ischaemic reperfusion brain injury. Nat Commun 7:10523. https://doi.org/10.1038/ncomms10523
Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14:133–150. https://doi.org/10.1038/nrneurol.2017.188
Toborek M, Seelbach MJ, Rashid CS, Andras IE, Chen L, Park M, Esser KA (2013) Voluntary exercise protects against methamphetamine-induced oxidative stress in brain microvasculature and disruption of the blood–brain barrier. Mol Neurodegener 8:22. https://doi.org/10.1186/1750-1326-8-22
Yang S, Mei SH, Jin H, Zhu B, Tian Y, Huo JP, Cui X, Guo AC, Zhao ZG (2017) Identification of two immortalized cell lines, ECV304 and bEnd3, for in vitro permeability studies of blood–brain barrier. PLoS ONE 12:e0187017. https://doi.org/10.1371/journal.pone.0187017
Yang QW, Huang QY, Hu ZP, Tang XQ (2019) Potential neuroprotective treatment of stroke: targeting excitotoxicity, oxidative stress, and inflammation. Front Neurosci 13:1036. https://doi.org/10.3389/fnins.2019.01036
Yu SB, Zhu L, Shen Q, Bai X, Di XH (2015) Recent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology. Behav Neurol 2015:103969. https://doi.org/10.1155/2015/103969
Vandenbroucke E, Mehta D, Minshall R, Malik AB (2008) Regulation of endothelial junctional permeability. Ann N Y Acad Sci 1123:134–145. https://doi.org/10.1196/annals.1420.016
Walker J, Winhusen T, Storkson JM, Lewis D, Pariza MW, Somoza E, Somoza V (2014) Total antioxidant capacity is significantly lower in cocaine-dependent and methamphetamine-dependent patients relative to normal controls: results from a preliminary study. Hum Psychopharmacol 29:537–543. https://doi.org/10.1002/hup.2430
Zhao Q, Pahlmark K, Smith ML, Siesjo BK (1994) Delayed treatment with the spin trap alpha-phenyl-n-tert-butyl nitrone (PBN) reduces infarct size following transient middle cerebral-artery occlusion in rats. Acta Physiol Scand 152:349–350. https://doi.org/10.1111/j.1748-1716.1994.tb09816.x
Acknowledgements
This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2016R1A6A1A03011325) and the Korean Government (MSIT) (NRF-2019R1C1C1005855, NRF-2018R1A2B6006175).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hwang, J.S., Cha, E.H., Park, B. et al. PBN inhibits a detrimental effect of methamphetamine on brain endothelial cells by alleviating the generation of reactive oxygen species. Arch. Pharm. Res. 43, 1347–1355 (2020). https://doi.org/10.1007/s12272-020-01284-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-020-01284-5